1. Home
  2. XAIR vs ALUR Comparison

XAIR vs ALUR Comparison

Compare XAIR & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.94

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.38

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
XAIR
ALUR
Founded
2011
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
18.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XAIR
ALUR
Price
$0.94
$1.38
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$11.00
$9.25
AVG Volume (30 Days)
113.1K
111.0K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,802,000.00
$17,208,000.00
Revenue This Year
$128.45
N/A
Revenue Next Year
$153.25
$9.02
P/E Ratio
N/A
N/A
Revenue Growth
147.74
N/A
52 Week Low
$0.90
$1.02
52 Week High
$11.20
$16.81

Technical Indicators

Market Signals
Indicator
XAIR
ALUR
Relative Strength Index (RSI) 28.71 43.38
Support Level $0.90 $1.46
Resistance Level $1.31 $1.71
Average True Range (ATR) 0.10 0.13
MACD 0.01 0.00
Stochastic Oscillator 11.84 36.36

Price Performance

Historical Comparison
XAIR
ALUR

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: